By Keith L. Carson
Volume 7, Issue 2 (Summer 2008)
There are many examples of efforts to make biosimilar products, such as every time a product is taken to a larger scale, and when an established product is transferred to another facility, including a contract manufacturing site. While most of these examples have resulted in products which were indistinguishable for all practical purposes, others revealed troubling differences during product characterization or clinical administration…
Citation: Carson KL. From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcess J, 2008; 7(2): 6. https://doi.org/10.12665/J72.KCarson
Posted online July 27, 2026